To include your compound in the COVID-19 Resource Center, submit it here.

University of Melbourne, Telix in radionuclide deal

The University of Melbourne granted Telix Pharmaceuticals Ltd.

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE